Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
02/2007
02/20/2007US7179932 Synthesis of cis-diols from aryl silanes
02/20/2007US7179901 Renal regulatory elements and methods of use thereof
02/20/2007US7179898 Human vanilloid receptor-like receptor
02/20/2007US7179889 Propionicin T1 polypeptide, a bacteriocin from Propionibacterium thoenii
02/20/2007US7179884 Polypeptides; proteolysis splitting; antitumor agents
02/20/2007US7179790 Brain natriuretic peptide
02/20/2007US7179786 Variants of the NK1 fragment of hepatocyte growth factor/scatter factor (HGF/SF) and their use
02/20/2007US7179650 Providing, in vitro, the cell with a nucleic acid segment encoding a polypeptide comprising wherein a Fas and/or TNFR1 mediated apoptosis pathway is inhibited in the cell
02/20/2007US7179648 Susceptible to baculovirus infection, useful for replicating, for gene expression using a baculovirus expression system
02/20/2007US7179647 For introducing DNA into organisms which produce large amounts of oils and, in particular, oils with a high content of unsaturated fatty acids
02/20/2007US7179646 Useful for obtaining tumour-selective gene expression in tumours having a mutated beta -catenin pathway; used to express genes encoding therapeutic proteins in colorectal cancer cells
02/20/2007US7179644 Kit for use in the generation of preferential expression vectors
02/20/2007US7179636 Using filtering process to detect, separate and concentrate microorganisms in liquid sample
02/20/2007US7179635 Peptides for use in culture media
02/20/2007US7179634 Methods for producing a polypeptide in a Bacillus cell
02/20/2007US7179633 For neutralizing alkaline wastewater having a pH of 11.5 to 12, efficiency
02/20/2007US7179631 Human deubiquitinating protease gene on chromosome 7 and its murine ortholog
02/20/2007US7179628 Transglutaminase
02/20/2007US7179627 Cyclooxygenase variants and methods of use
02/20/2007US7179626 Changing the amino acid at position 576 of SEQ ID NO: 3 to a Phe residue, whereupon the specificity of the potato tuber lipoxygenase for position 11 of arachidonic acid is enhanced
02/20/2007US7179625 vectors, host cells, selective binding agents, such as antibodies, and methods for producing huE3 alpha polypeptides
02/20/2007US7179623 Method of producing amino acids using E. coli transformed with sucrose PTS genes
02/20/2007US7179621 Pigment epithelium-derived factor: sequence of the PEDF gene
02/20/2007US7179620 Elongation of fatty acids(ELF) polypeptides and carrier mixtures administered for prophylaxis of vision defects
02/20/2007US7179618 Streptavidin proteins
02/20/2007US7179608 Therapeutic antiangiogenic compositions and methods
02/20/2007US7179603 Detection and identification of enteric bacteria
02/20/2007US7179599 Mobilization of viral genomes from T-DNA using site-specific recombination systems
02/20/2007US7179467 DCMP2 polypeptide
02/20/2007US7179463 Treatment of alzheimer's disease
02/20/2007US7179460 Probiotic lactobacillus and bifidobacterium for treatment, prevention and/or reduction of allergenicity, gastrointestinal, cell proliferative and cholesterol disorders
02/20/2007US7179458 Lactobacilli expressing biologically active polypeptides and uses thereof
02/20/2007US7179448 Recombinant constructs of Borrelia burgdorferi
02/20/2007CA2346997C Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto
02/20/2007CA2321645C Dna sequences containing a conjugative transfer mechanism
02/18/2007CA2556456A1 Method of regulation of bacterial persister status
02/15/2007WO2007019466A2 Biofilm-immune cell coculture system and its use
02/15/2007WO2007018853A2 Secretion of antibodies without signal peptides from bacteria
02/15/2007WO2007018194A1 Method for producing cercosporamide
02/15/2007WO2007018143A1 Use of gene which varies in amount of expression during the course of transition from precancer to cancer
02/15/2007WO2007018062A1 Eucalyptus globulus monoterpene synthetase gene
02/15/2007WO2007018049A1 Antigen capable of inducing neutralizing antibody for high risk-type human papillomavirus
02/15/2007WO2007017710A1 Process for the preparation of aspartate and derived amino acids like lysine, threonine, isoleucine, methionine, homoserine, or valine employing a microorganism with enhanced isocitrate lyase and/or malate synthase expression
02/15/2007WO2007017601A1 Bacterial culture medium in a minimum inorganic medium, comprising gentisate and/or one of the precursors thereof, and use of 3-hydroxybenzoate in one such medium
02/15/2007WO2007017526A1 Process for the preparation of aspartate and derived amino acids like lysine, threonine, isoleucine, methionine, or homoserine employing a microorganism with enhanced isocitrate lyase and/or malate synthase expression
02/15/2007WO2007016792A1 Orf11 from campylobacter jejuni is a sialate-o-acetyltransferase
02/15/2007WO2006135632A3 System for sustained microbial production of hydrogen gas in a bioreactor
02/15/2007WO2006134623B1 Method for increasing the survival of bacterial strains of the rhizobium genus
02/15/2007WO2006036757A3 High temperature flow-through device for rapid solubilization and analysis
02/15/2007WO2005100582A3 Methods for degrading or converting plant cell wall polysaccharides
02/15/2007WO2005056570A3 Production of amino sugars
02/15/2007WO2005003289A8 Ap1 amine oxidase variants
02/15/2007US20070037271 Vitrification apparatus for microdrop vitrification of cells and a method of microdrop vitrification of cells using the apparatus
02/15/2007US20070037269 Mutants of desoxycytidine kinase having extended enzymatic activity
02/15/2007US20070037265 Genetically modified E. coli strain comprising the following modifications: inactivation or deletion of an acetate kinase gene, a fumarate reductase gene, a pyruvate formatelyase gene, an alcohol dehydrogenase gene, and a methylglyoxal synthase gene
02/15/2007US20070037264 Using trangenic microorganism having nitrilase and amidase activities to convert (E,Z)-2-methyl-2-butenenitrile into (E and Z)-2-methyl-2-butenoic acids
02/15/2007US20070037263 Novel acetoacetyl-coa reductase and process for producing optically active alcohol
02/15/2007US20070037262 Genes encoding genetic stability, gene expression and folding proteins
02/15/2007US20070037261 Genes encoding carbon metabolism and energy-producing proteins
02/15/2007US20070037258 Methods and compositions for enhancing protein folding
02/15/2007US20070037257 Nucleic acid, expression vectors and host cells for synthetic genes, chosen from a gram negative bacteria, yeast, or mammalian cell; zinc-endopeptidases that specifically cleave the synaptosomal proteins, SNAP-25, VAMP, or syntaxin at discrete sites
02/15/2007US20070037251 Novel protein expression system
02/15/2007US20070037250 Method for obtaining precursor Z and use thereof for the production of a means for therapy of human molybdenum cofactor deficiency
02/15/2007US20070037248 Production of modified glycoproteins having multiple antennary structures
02/15/2007US20070037247 Polypeptide having a thermostable ribonuclease H activity; highly valuable for genetic engineering
02/15/2007US20070037246 Methods and compositions for enhanced protein expression and purification
02/15/2007US20070037218 Human gene critical to fertility
02/15/2007US20070037216 Dual expression vector system for antibody expression in bacterial and mammalian cells
02/15/2007US20070037190 DNA ligase mutants
02/15/2007US20070037159 Tetrahydrofolate synthetase gene
02/15/2007US20070037145 drug screening; for carcinomas, especially lymphoma carcinomas
02/15/2007US20070036880 Isolation of Pseudomonas alcaligenes for bio-decaffeination of caffeine containing solutions
02/15/2007US20070036824 Optimized expression of hpv 58 l1 in yeast
02/15/2007US20070036823 Development of a live, attenuated, recombinant vaccine for Brucellosis
02/15/2007US20070036822 Selection system containing non-antibiotic resistance selection marker
02/15/2007US20070036820 Yeast compositions useful as anti-aging dietary supplements
02/15/2007US20070036815 Ricin-like toxins for treatment of cancer
02/15/2007US20070036814 Antibody binding to polypeptide of given sequence; antisera; use in wound healing, blocking adherence to indwelling medical devices, vaccines
02/15/2007US20070036812 polypeptide with binding to antigen and is recognized by cytotoxic T lymphocytes; use as cancer vaccine
02/15/2007US20070036763 Interleukin-17 receptor homologue
02/15/2007US20070036719 antibodies and their use for detecting, imaging, staging, treating and monitoring of prostate cancer, and/or metastasis; prostate specific membrane antigen (PSMA)
02/15/2007DE102005037349A1 Verfahren für die kontinuierliche zielgerichtete Evolution von Proteinen in vivo Process for the continuous evolution of targeted proteins in vivo
02/15/2007CA2618769A1 Orf11 from campylobacter jejuni is a sialate-o-acetyltransferase
02/15/2007CA2618694A1 Genes from actinobacillus succinogenes 13oz (atcc 55618) for production of chemicals from the a. succinogenes c4-pathway
02/15/2007CA2618631A1 Method for producing cercosporamide
02/15/2007CA2618273A1 Expression of an active carrier for xylose in genetically modified saccharomyces cerevisiae
02/15/2007CA2615776A1 Secretion of antibodies without signal peptides from bacteria
02/14/2007EP1752534A1 High-speed pcr using high-speed dna polymerase
02/14/2007EP1752529A1 Method and device for controlling temperature
02/14/2007EP1752525A1 Amylase variants
02/14/2007EP1752160A2 Epitope sequences
02/14/2007EP1751297A2 Biosynthetic production of 4-amino-4-deoxychorismate (adc) and [3,4r]-4-amino-3-hydroxycyclohexa-1,5-diene-1-carboxylic acid (3,4-cha)
02/14/2007EP1751292A1 A method to produce succinic acid from raw hydrolysates
02/14/2007EP1751286A2 Biosynthetic gene cluster for the production of a complex polyketide
02/14/2007EP1751284A2 Method and compositions for detecting botulinum neurotoxin
02/14/2007EP1751283A1 Fed-batch fermentation process and culture medium for the production of plasmid dna in e.coli on a manufacturing scale
02/14/2007EP1751279A2 Nucleic acids and polypeptides involved in the production of cryptophycin
02/14/2007EP1751273A1 Compound ws 727713
02/14/2007EP1751272A2 Production of tacrolimus (fk-506) using new streptomyces species
02/14/2007EP1751271A2 Methods and compositions for the dietary management of autoimmune disorders